Global Invacom Group Limited (SGX:QS9)
0.0200
-0.0020 (-9.09%)
At close: Aug 1, 2025, 5:00 PM SGT
Verve Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.